Morgan Stanley’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $138K | Sell |
76,512
-23,283
| -23% | -$41.9K | ﹤0.01% | 6010 |
|
|
2025
Q1 | $191K | Buy |
99,795
+11,283
| +13% | +$21.6K | ﹤0.01% | 5747 |
|
|
2024
Q4 | $191K | Buy |
88,512
+83,712
| +1,744% | +$181K | ﹤0.01% | 5801 |
|
|
2024
Q3 | $8.54K | Buy |
4,800
+1,500
| +45% | +$2.67K | ﹤0.01% | 6767 |
|
|
2024
Q2 | $4.22K | Buy |
3,300
+500
| +18% | +$640 | ﹤0.01% | 6891 |
|
|
2024
Q1 | $10.6K | Sell |
2,800
-2,800
| -50% | -$10.6K | ﹤0.01% | 6681 |
|
|
2023
Q4 | $18.3K | Buy |
5,600
+4,300
| +331% | +$14K | ﹤0.01% | 6695 |
|
|
2023
Q3 | $4.26K | Buy |
1,300
+500
| +63% | +$1.64K | ﹤0.01% | 6946 |
|
|
2023
Q2 | $3.58K | Hold |
800
| – | – | ﹤0.01% | 7055 |
|
|
2023
Q1 | $3.86K | Hold |
800
| – | – | ﹤0.01% | 7116 |
|
|
2022
Q4 | $2.5K | Sell |
800
-252
| -24% | -$789 | ﹤0.01% | 7312 |
|
|
2022
Q3 | $4K | Buy |
1,052
+252
| +32% | +$958 | ﹤0.01% | 7299 |
|
|
2022
Q2 | $3K | Sell |
800
-3
| -0.4% | -$11 | ﹤0.01% | 7512 |
|
|
2022
Q1 | $3K | Buy |
803
+3
| +0.4% | +$11 | ﹤0.01% | 7683 |
|
|
2021
Q4 | $4K | Hold |
800
| – | – | ﹤0.01% | 7683 |
|
|
2021
Q3 | $6K | Hold |
800
| – | – | ﹤0.01% | 7446 |
|
|
2021
Q2 | $8K | Hold |
800
| – | – | ﹤0.01% | 7294 |
|
|
2021
Q1 | $12K | Buy |
+800
| New | +$12K | ﹤0.01% | 6885 |
|